RecruitingNot Applicable

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

France500 participantsStarted 2022-12-02

Plain-language summary

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Former or active intravenous and/or nasal drug user * Person on opiate substitution therapy Exclusion Criteria: * Person with known active viral infection(s)

What they're measuring

Number of person with an active hepatitis C infection

Timeframe: Day 1

Number of person with an active hepatitis B infection

Timeframe: Day 1

Number of person with an active AIDS infection

Timeframe: Day 1

Trial details

NCT IDNCT05390424

SponsorUniversity Hospital, Rouen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01

Contact for this trial

Ghassan RIACHI, MD

+3323288 ghassan.riachi@chu-rouen.fr

View on ClinicalTrials.gov More Hepatitis B trials